CL2018003873A1 - Proceso de preparación del inhibidor de inmunoproteasoma de péptido epoxicetona, y sus precursores. - Google Patents
Proceso de preparación del inhibidor de inmunoproteasoma de péptido epoxicetona, y sus precursores.Info
- Publication number
- CL2018003873A1 CL2018003873A1 CL2018003873A CL2018003873A CL2018003873A1 CL 2018003873 A1 CL2018003873 A1 CL 2018003873A1 CL 2018003873 A CL2018003873 A CL 2018003873A CL 2018003873 A CL2018003873 A CL 2018003873A CL 2018003873 A1 CL2018003873 A1 CL 2018003873A1
- Authority
- CL
- Chile
- Prior art keywords
- precursors
- preparation process
- epoxy ketone
- ketone peptide
- immunoproteasome inhibitor
- Prior art date
Links
- 239000002243 precursor Substances 0.000 title abstract 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 title 1
- 229940126097 immunoproteasome inhibitor Drugs 0.000 title 1
- 238000002360 preparation method Methods 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- DLFVBJFMPXGRIB-UHFFFAOYSA-N Acetamide Chemical compound CC(N)=O DLFVBJFMPXGRIB-UHFFFAOYSA-N 0.000 abstract 2
- QLNJFJADRCOGBJ-UHFFFAOYSA-N propionamide Chemical compound CCC(N)=O QLNJFJADRCOGBJ-UHFFFAOYSA-N 0.000 abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/14—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D295/145—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/15—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals with the ring nitrogen atoms and the carbon atoms with three bonds to hetero atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
- C07C229/36—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings with at least one amino group and one carboxyl group bound to the same carbon atom of the carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D301/00—Preparation of oxiranes
- C07D301/02—Synthesis of the oxirane ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/12—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms
- C07D303/32—Compounds containing oxirane rings with hydrocarbon radicals, substituted by singly or doubly bound oxygen atoms by aldehydo- or ketonic radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D303/00—Compounds containing three-membered rings having one oxygen atom as the only ring hetero atom
- C07D303/02—Compounds containing oxirane rings
- C07D303/38—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C07D303/46—Compounds containing oxirane rings with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals by amide or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Epoxy Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
Abstract
EN LA PRESENTE SE DESCRIBEN MÉTODOS PARA PREPARAR [(2S,3R)-N-[(2S)-3-(CICLOPENT-1-EN-1-IL)-1-[(2R)-2-METILOXIRAN-2-IL]-1-OXOPROPAN-2-IL]-3-HIDROXI-3-(4-METOXIFENIL)-2-[(2S)-2-[2-(MORFOLIN-4-IL)ACETAMIDO]PROPANAMIDO]PROPANAMIDA (COMPUESTO “G”) Y SUS PRECURSORES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662356178P | 2016-06-29 | 2016-06-29 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2018003873A1 true CL2018003873A1 (es) | 2019-06-21 |
Family
ID=59351085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2018003873A CL2018003873A1 (es) | 2016-06-29 | 2018-12-28 | Proceso de preparación del inhibidor de inmunoproteasoma de péptido epoxicetona, y sus precursores. |
Country Status (17)
Country | Link |
---|---|
US (3) | US10781192B2 (es) |
EP (2) | EP4296257A3 (es) |
JP (2) | JP7065044B2 (es) |
KR (2) | KR102524751B1 (es) |
CN (1) | CN109641860B (es) |
AR (1) | AR108919A1 (es) |
AU (1) | AU2017290147B2 (es) |
BR (1) | BR112018077250A2 (es) |
CA (1) | CA3029418A1 (es) |
CL (1) | CL2018003873A1 (es) |
CO (1) | CO2019000866A2 (es) |
EA (1) | EA201990157A1 (es) |
IL (2) | IL263771B2 (es) |
MX (1) | MX2018016386A (es) |
SG (1) | SG11201811506UA (es) |
TW (1) | TWI751177B (es) |
WO (1) | WO2018005781A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL263771B2 (en) * | 2016-06-29 | 2023-09-01 | Kezar Life Sciences | Preparation process of immunoproteasome epoxytone peptide inhibitor and its precursors |
Family Cites Families (26)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
US5340736A (en) | 1991-05-13 | 1994-08-23 | The President & Fellows Of Harvard College | ATP-dependent protease and use of inhibitors for same in the treatment of cachexia and muscle wasting |
AU4499697A (en) | 1996-09-13 | 1998-04-02 | New York University | Method for treating parasitic diseases with proteasome inhibitors |
WO2004043374A2 (en) | 2002-11-06 | 2004-05-27 | Dana-Farber Cancer Institute, Inc. | Methods and compositions for treating cancer using proteasome inhibitors |
US7687456B2 (en) | 2005-11-09 | 2010-03-30 | Proteolix, Inc. | Compounds for enzyme inhibition |
NZ597545A (en) | 2006-06-19 | 2013-07-26 | Proteolix Inc | Peptide epoxyketones for proteasome inhibition |
US7442830B1 (en) | 2007-08-06 | 2008-10-28 | Millenium Pharmaceuticals, Inc. | Proteasome inhibitors |
EP2207791B2 (en) | 2007-10-04 | 2019-08-07 | Onyx Therapeutics, Inc. | Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides |
CN101525370A (zh) | 2008-03-06 | 2009-09-09 | 海南建邦制药科技有限公司 | 一种新型高效多肽合成缩合剂 |
MX368109B (es) | 2008-10-21 | 2019-09-18 | Onyx Therapeutics Inc | Terapia de combinacion con epoxicetonas peptidicas. |
TWI504598B (zh) | 2009-03-20 | 2015-10-21 | Onyx Therapeutics Inc | 結晶性三肽環氧酮蛋白酶抑制劑 |
US8853147B2 (en) | 2009-11-13 | 2014-10-07 | Onyx Therapeutics, Inc. | Use of peptide epoxyketones for metastasis suppression |
US8697646B2 (en) | 2010-04-07 | 2014-04-15 | Onyx Therapeutics, Inc. | Crystalline peptide epoxyketone immunoproteasome inhibitor |
US8609610B2 (en) | 2011-02-18 | 2013-12-17 | Trustees Of Dartmouth College | Inhibitors of the trypsin-like site of the proteasome and methods of use thereof |
EP2705027B1 (en) | 2011-05-02 | 2015-06-03 | Gilead Sciences, Inc. | Amorphous solid salts of Cobicistat (GS-9350) |
KR20220088949A (ko) | 2012-05-08 | 2022-06-28 | 오닉스 세라퓨틱스, 인크. | 펩티드 프로테아좀 억제제 제제화를 위한 사이클로덱스트린 복합체화 방법 |
EP2867202B1 (en) | 2012-06-29 | 2017-08-09 | Nissan Chemical Industries, Ltd. | Method for producing stereoselective epoxyketone compound |
JP2016501831A (ja) | 2012-10-11 | 2016-01-21 | エフ.ホフマン−ラ ロシュ アーゲーF. Hoffmann−La Roche Aktiengesellschaft | ケトアミド免疫プロテアソーム阻害剤 |
RU2015117581A (ru) | 2012-10-12 | 2016-12-10 | Ф. Хоффманн-Ля Рош Аг | Макроциклические кетоамидные ингибиторы иммунопротеасом |
TW201422255A (zh) * | 2012-10-24 | 2014-06-16 | Onyx Therapeutics Inc | 用於蛋白酶體抑制劑之調整釋放製劑 |
AR095426A1 (es) * | 2013-03-14 | 2015-10-14 | Onyx Therapeutics Inc | Inhibidores tripeptídicos de la epoxicetona proteasa |
KR102365509B1 (ko) * | 2013-03-14 | 2022-02-21 | 오닉스 세라퓨틱스, 인크. | 트리펩타이드 에폭시 케톤 프로테이스 억제제 |
TWI662047B (zh) | 2013-03-14 | 2019-06-11 | 歐尼克斯治療公司 | 三肽環氧酮蛋白酶體抑制劑 |
CN104710507B (zh) | 2013-12-11 | 2018-08-14 | 深圳翰宇药业股份有限公司 | 一种卡非佐米的制备方法 |
CN104230857A (zh) | 2014-08-19 | 2014-12-24 | 上海皓元生物医药科技有限公司 | 卡非佐米(Carfilzomib)的中间体化合物的制备方法及其中间体化合物 |
IL263771B2 (en) * | 2016-06-29 | 2023-09-01 | Kezar Life Sciences | Preparation process of immunoproteasome epoxytone peptide inhibitor and its precursors |
-
2017
- 2017-06-29 IL IL263771A patent/IL263771B2/en unknown
- 2017-06-29 AR ARP170101808A patent/AR108919A1/es unknown
- 2017-06-29 WO PCT/US2017/039975 patent/WO2018005781A1/en unknown
- 2017-06-29 BR BR112018077250-0A patent/BR112018077250A2/pt unknown
- 2017-06-29 TW TW106121701A patent/TWI751177B/zh active
- 2017-06-29 US US16/312,688 patent/US10781192B2/en active Active
- 2017-06-29 EA EA201990157A patent/EA201990157A1/ru unknown
- 2017-06-29 EP EP23191555.4A patent/EP4296257A3/en active Pending
- 2017-06-29 AU AU2017290147A patent/AU2017290147B2/en active Active
- 2017-06-29 KR KR1020197002872A patent/KR102524751B1/ko active IP Right Grant
- 2017-06-29 KR KR1020237013160A patent/KR102571568B1/ko active IP Right Grant
- 2017-06-29 MX MX2018016386A patent/MX2018016386A/es unknown
- 2017-06-29 EP EP17740180.9A patent/EP3478669B1/en active Active
- 2017-06-29 JP JP2018568194A patent/JP7065044B2/ja active Active
- 2017-06-29 SG SG11201811506UA patent/SG11201811506UA/en unknown
- 2017-06-29 IL IL302234A patent/IL302234A/en unknown
- 2017-06-29 CA CA3029418A patent/CA3029418A1/en active Pending
- 2017-06-29 CN CN201780053331.3A patent/CN109641860B/zh active Active
-
2018
- 2018-12-28 CL CL2018003873A patent/CL2018003873A1/es unknown
-
2019
- 2019-01-29 CO CONC2019/0000866A patent/CO2019000866A2/es unknown
-
2020
- 2020-09-09 US US17/015,450 patent/US11498907B2/en active Active
-
2022
- 2022-04-25 JP JP2022071492A patent/JP7392031B2/ja active Active
- 2022-10-13 US US17/965,064 patent/US11976053B2/en active Active
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY37381A (es) | Compuestos que inhiben proteasas 3c y 3cl y métodos de uso de los mismos | |
MA51082A (fr) | Un sel de sodium du n-((1,2,3,5,6,7-hexahydro-s-indacen-4-yl)carbamoyl)-1-isopropyl-1h-pyrazole-3-sulfonamide | |
EA201890749A1 (ru) | ИНГИБИТОРЫ АЦЕТИЛ-КоА-КАРБОКСИЛАЗЫ (ACC) И ИХ ПРИМЕНЕНИЕ | |
CL2016003422A1 (es) | Inhibidores de demetilasa-1 específico de lisina | |
TR2021016542A2 (tr) | Plazma bazlı filmler ve bunları üretme ve kullanma usulleri. | |
CL2018003132A1 (es) | Inhibidores de la arginasa y sus aplicaciones terapéuticas. | |
CL2016003423A1 (es) | Inhibidores de demetilasa-1 específico de lisina | |
CL2019000189A1 (es) | Nuevos anticuerpos anti-claudina y sus métodos de uso. (divisional solicitud 201801481) | |
EA201790407A1 (ru) | Зонды для визуализации белка хантингтина | |
MY174254A (en) | Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor | |
BR112018012177A2 (pt) | ?moduladores de hidantação de canais kv 3? | |
MY202185A (en) | Carbamoyl phenylalaninol compounds and uses therof | |
BR112017000730A2 (pt) | derivados de pirrolidinona como inibidores de metap-2 | |
CY1123267T1 (el) | Κρυσταλλικες μορφες 2-(tpit-boytyλamino)-4-((1r,3r,4r)-3-yδpoξy-4-μεθυλοκυκλοεξυλαμινο)-πυριμιδινο-5-καρβοξαμιδιου | |
EA201790400A1 (ru) | Зонды для визуализации белка хантингтина | |
BR112019000895A2 (pt) | método para a produção microbiana de capsaicinoides naturais específicos | |
CL2019000049A1 (es) | Procesos para la preparación de oxipicolinamidas 4 - alkoxi - (acil o aquil). | |
MX2017008908A (es) | Proceso para la hidrólisis de queratina empleando proteasas. | |
FR3051878B1 (fr) | Etancheite statique haute pression | |
EA201892051A1 (ru) | Фармацевтические композиции для лечения злокачественного новообразования | |
EA202091259A1 (ru) | Способ получения опикапона и его интермедиатов | |
BR112017019176A2 (pt) | processos para a preparação de fluorocetolídeos | |
CL2018003873A1 (es) | Proceso de preparación del inhibidor de inmunoproteasoma de péptido epoxicetona, y sus precursores. | |
CY1124974T1 (el) | Διαδικασια για την παρασκευη βορτιοξετινης hbr αλφα-μορφης | |
MX2020005707A (es) | Profarmacos de creatina, composiciones y metodos de uso de estos. |